Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02677896 |
|---|---|
| Brief Title: | A Study of Enzalutamide Plus Androgen Deprivation Therapy (ADT) Versus Placebo Plus ADT in Patients With Metastatic Hormone Sensitive Prostate Cancer (mHSPC) (ARCHES) |
| First Submitted : | February 5, 2016 |
| First Submitted that Met QC Criteria : | February 5, 2016 |
| First Posted : | February 9, 2016 (Estimate) |
| Results First Submitted : | January 8, 2020 |
| Results First Submitted that Met QC Criteria : | January 8, 2020 |
| Results First Posted : | January 21, 2020 |
| Certification/Extension First Submitted : | October 1, 2019 |
| Certification/Extension First Submitted that Met QC Criteria : | October 1, 2019 |
| Certification/Extension First Posted : | October 9, 2019 |
| Last Update Submitted that Met QC Criteria : | April 18, 2024 |
| Last Update Posted : | April 19, 2024 |